Clinical Trials Logo

Aging clinical trials

View clinical trials related to Aging.

Filter by:

NCT ID: NCT05322343 Recruiting - Depression Clinical Trials

Biobank and Brain Health in Bordeaux.

B-cube
Start date: March 22, 2022
Phase:
Study type: Observational [Patient Registry]

B cube is a new generation cohort to study the determinants and natural history of brain aging, using molecular epidemiology, in a representative sample (N=2000) of the general population from the age of 55 (the approximate age of onset of the first cognitive disorders and a target population particularly receptive to prevention messages). Special interest will be given to nutrition, a promising environmental exposure for prevention.

NCT ID: NCT05315895 Recruiting - Cancer Clinical Trials

The Dampness Syndrome of Chinese Medicine Cohort Study

DACOS
Start date: June 6, 2022
Phase:
Study type: Observational [Patient Registry]

The researchers plain to build a large-scale, longitudinal, prospective cohort characterized by TCM dampness syndrome. With the biobank of this cohort the investigators want to find the causality between TCM dampness syndrome and clinical chronic diseases and a new way to treat clinical disease.

NCT ID: NCT05313490 Recruiting - Aging Clinical Trials

Exercise Fatiguability in Older Adults: The Protective Effects of Dietary Nitrate Supplementation

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

Vascular and skeletal muscle function decline with age and are associated with decreased nitric oxide (NO) bioavailability. Dietary nitrate supplementation in the form of beet root juice increases NO bioavailability and improves exercise tolerance in younger adults, yet its effects on fatigability in older adults are largely unknown. The proposed research will investigate the impact of increased NO bioavailability on vascular function, skeletal muscle bioenergetics, and fatigability in older (≥65 yrs) men and women.

NCT ID: NCT05310123 Active, not recruiting - Aging Clinical Trials

AC-11 Supplement and Biological Aging

Start date: May 26, 2021
Phase: Phase 2
Study type: Interventional

This is a prospective non-randomized clinical study of 24 patients to evaluate the effects of the AC-11®. The study will evaluate the effectiveness of the supplement's ability to reverse epigenetic markers of biological age. The duration of the study will be 6 months.

NCT ID: NCT05309577 Recruiting - Alzheimer Disease Clinical Trials

Self-Care for Dementia Caregivers

Care2
Start date: March 7, 2023
Phase: N/A
Study type: Interventional

The Self-care for Dementia Caregivers Study is a behavioral health intervention that uses digital monitoring tools and motivational health coaching to help caregivers of persons with dementia engage in a regular routine of self-care. Participants wear an apple watch for the objective collection of sleep-wake rhythms. They receive personalized feedback on their sleep-wake rhythms via a new app. Health coaches call participants weekly, for 6 weeks to help participants meet their health/sleep goals and promote self-knowledge of regular routines. Participants will help the study team improve the design elements and content of the mobile app. The goal of this intervention is to reduce psychological distress and caregiver burden.

NCT ID: NCT05309278 Recruiting - Aging Clinical Trials

Remote Physical and Cognitive Training Effects in Older Adults at Increased Risk of Clinical-functional Vulnerability

Start date: July 26, 2022
Phase: N/A
Study type: Interventional

This study is a randomized, single-blind, parallel, controlled, superiority trial. The main objective is to verify the chronic effects of a remote 12-week low-intensity physical training program alone or in combination with cognitive training on functional, cognitive, and occupational capacity, as well as on the self-reported quality of life.

NCT ID: NCT05309161 Completed - Aging Clinical Trials

Efficacy Testing of Crassocephalum Rabens Extract Capsules

Start date: March 14, 2022
Phase: N/A
Study type: Interventional

This study is to investigate the improveing effects of the Crassocephalum rebens extract on skin conditions in normal people.

NCT ID: NCT05307666 Enrolling by invitation - Aging Clinical Trials

MinMed: Do Older Adults do Better With Less Medication

Start date: July 28, 2022
Phase: Phase 4
Study type: Interventional

Many health care providers believe "less-is-more" for older adults, and evidence suggests minimizing certain medications might improve health outcomes. While this evidence focuses on specific medications believed potentially problematic for seniors, it is really adverse reactions to COMMON medications (e.g. medications lowering blood sugar or treating pain) that bring older adults to emergency departments. Knowing recommended drug doses are lower in seniors, and knowing most adverse drug reactions are dose-related, the investigators are organizing primary care providers (family physicians and nurse practitioners) to invite their patients 80 years and older on 6 or more medications to review with them whether some medications could be safely reduced. For drugs treating a symptom (e.g. heartburn), patients and providers will work together to find the lowest dose that provides the same benefit. For drugs that lower blood pressure or blood sugar, doses will be adjusted to keep blood pressure and blood sugar in the upper end of the target range, a range many providers feel to be safer for older adults. Each provider will invite half their eligible patients to a minimization visit at the start of the study, and invite the other half later - after the health effects of minimizing the early group's medications is assessed. To do this, investigators will compare early minimizers to those whose medicines have not yet changed using electronic health data routinely collected on all Albertans. We hypothesize that minimizing medications will prolong independence, reduce mortality and hospitalization, and improve quality of life. It is important to recognize that the intervention (reviewing all medications and determining the lowest effective doses) is already widely recommended as best practice when prescribing for older adults. Despite this however, such medication reviews only infrequently take place. In this study investigators hope to demonstrate that family physicians can minimize their own prescribing, and that organizing providers in a way that permits such reviews to take place can provide health benefits to patients.

NCT ID: NCT05307627 Suspended - Aging Clinical Trials

The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging

Start date: March 14, 2022
Phase:
Study type: Observational

This retrospective, observational study will assess the health status of short- and long-term low-dose naltrexone (LDN) users.

NCT ID: NCT05302596 Active, not recruiting - Obesity Clinical Trials

Semaglutide Use in Elderly Obese Patients

Start date: September 1, 2022
Phase: Phase 4
Study type: Interventional

This is a single-center, prospective, controlled, randomized and open label study to investigate the effect of the semaglutide addition to standard of care weight loss intervention (personalized lifestyle and exercise) in elderly obese subjects on body weight and body composition as assessed by DEXA.